Ergoteles’s MediciNova MNOV Stock Holding History

Ergoteles’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,117	Closed	-$71.6K	–	536
2023 Q2	$71.6K	Sell	31,117 -38,123	-55%	-$84K	﹤0.01%	935
2023 Q1	$150K	Sell	69,240 -41,756	-38%	-$95.6K	0.01%	1063
2022 Q4	$228K	Buy	+110,996	New	+$245K	0.01%	1022
2022 Q1	–	Sell	-10,460	Closed	-$28K	–	1479
2021 Q4	$28K	Sell	10,460 -84,035	-89%	-$281K	﹤0.01%	1191
2021 Q3	$358K	Sell	94,495 -82,837	-47%	-$315K	0.01%	724
2021 Q2	$754K	Buy	+177,332	New	+$764K	0.02%	616

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ergoteles's MNOV Position: Q3 2023 in Review

Ergoteles sold out of MediciNova (MNOV) in Q3 2023, closing a stake of 31,117 shares — an estimated $71.6K sold.

Ergoteles first reported a position in MNOV in Q2 2021 and held it in 6 quarters. The position peaked at $754K in Q2 2021. 30 funds tracked by Wall St. Rank hold MNOV as of Q3 2023.

Ergoteles reported no remaining MediciNova position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 31,117 MediciNova shares in Q3 2023, an estimated $71.6K.
Ergoteles first reported a position in MediciNova in Q2 2021 and held it in 6 quarters.
Ergoteles's MediciNova position peaked at $754K in Q2 2021.
30 funds tracked by Wall St. Rank held MediciNova as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.